Tóth FD - Search Results

1

Two parallel routes of the complement-mediated antibody-dependent enhancement of HIV-1 infection.

Prohászka Z, Nemes J, Hidvégi T, Tóth FD, Kerekes K, Erdei A, Szabó J, Ujhelyi E, Thielens N, Dierich MP, Späth P, Ghebrehiwet B, Hampl H, Kiss J, Arlaud G, Füst G. Prohászka Z, et al. Among authors: toth fd. AIDS. 1997 Jul;11(8):949-58. doi: 10.1097/00002030-199708000-00002. AIDS. 1997. PMID: 9223728

2

Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection.

Tóth FD, Szabó B, Ujhelyi E, Pálóczi K, Horváth A, Füst G, Kiss J, Bánhegyi D, Hollán SR. Tóth FD, et al. AIDS. 1991 Mar;5(3):263-8. doi: 10.1097/00002030-199103000-00003. AIDS. 1991. PMID: 1676275

3

Neutralizing and enhancing antibodies measured in complement-restored serum samples from HIV-1-infected individuals correlate with immunosuppression and disease.

Füst G, Tóth FD, Kiss J, Ujhelyi E, Nagy I, Bánhegyi D. Füst G, et al. Among authors: toth fd. AIDS. 1994 May;8(5):603-9. doi: 10.1097/00002030-199405000-00005. AIDS. 1994. PMID: 7914732

4

Competition of complement proteins and specific antibodies for binding to HIV-1 envelope antigens.

Füst G, Prohászka Z, Hidvégi T, Thielens N, Arlaud G, Tóth FD, Kiss J, Dierich MP, Ujhelyi E. Füst G, et al. Among authors: toth fd. Acta Microbiol Immunol Hung. 1994;41 Suppl:27-31. Acta Microbiol Immunol Hung. 1994. PMID: 8075944 No abstract available.

5

Strong correlation between the complement-mediated antibody-dependent enhancement of HIV-1 infection and plasma viral load.

Szabó J, Prohászka Z, Tóth FD, Gyuris A, Segesdi J, Bánhegyi D, Ujhelyi E, Minárovits J, Füst G. Szabó J, et al. Among authors: toth fd. AIDS. 1999 Oct 1;13(14):1841-9. doi: 10.1097/00002030-199910010-00005. AIDS. 1999. PMID: 10513641

6

Role of Complement and Antibodies in the Control and Facilitation of HIV Disease.

Prohászka Z, Tóth FD, Bánhegyi D, Füst G. Prohászka Z, et al. Among authors: toth fd. Pathol Oncol Res. 1997;3(4):296-302. doi: 10.1007/BF02904290. Pathol Oncol Res. 1997. PMID: 11173651 Free article.

7

Significant decrease of the enhancement/neutralization index in HIV patients during highly active antiretroviral therapy (HAART).

Bánhegyi D, Bácsi A, Tóth FD, Prohászka Z, Horváth A, Beck Z, Kónya J, Füst G. Bánhegyi D, et al. Among authors: toth fd. Immunol Lett. 2003 Oct 9;89(1):25-30. doi: 10.1016/s0165-2478(03)00106-8. Immunol Lett. 2003. PMID: 12946861

8

Neutralizing antibodies and serum interferon levels in the different stages of HIV infection.

Szabó B, Tóth FD, Kiss J, Ujhelyi E, Füst G, Horváth A, Hollán SR. Szabó B, et al. Among authors: toth fd. Acta Virol. 1990 Apr;34(2):164-70. Acta Virol. 1990. PMID: 1975977

9

Complement-dependent cytotoxicity of antibodies reactive with HIV-induced cell surface antigens in HIV-carrying haemophiliacs.

Tóth FD, Kiss J, Szabó B, Füst G, Ujhelyi E, Hollán SR, Váczi L. Tóth FD, et al. Acta Virol. 1989 Dec;33(6):521-6. Acta Virol. 1989. PMID: 2576594

10

Comparative study of antibodies that are associated with disease progression in HIV disease.

Tóth FD, Süsal C, Ujhelyi E, Bánhegyi D, Kiss J, Daniel V, Nagy I, Opelz G, Füst G. Tóth FD, et al. Immunol Lett. 1994 Jun;41(1):33-6. doi: 10.1016/0165-2478(94)90053-1. Immunol Lett. 1994. PMID: 7959901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters